Maria A Morozova

5PUBLICATIONS
62CO-AUTHORS
Disease surveillanceNeurology and neuromuscular diseasesRegenerative medicine (incl. stem cells)Cardiology (incl. cardiovascular diseases)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 12, 2025
The Efficacy and Safety of BCD-180, an Anti-TRBV9+ T cell Monoclonal Antibody, in Patients with Active Radiographic Axial Spondyloarthritis: 36-week Results from the Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Study ELEFTA.

E L Nasonov, V I Mazurov, A M Lila

|Dec 18, 2024
[Natural history of spinal muscular atrophy type I].

D V Vlodavets, Yu N Linkova, A V Zinkina-Orikhan

|Oct 26, 2022
[The efficacy and safety of eculizumab biosimilar in patients with paroxysmal nocturnal hemoglobinuria. Results of a phase III randomized open-label comparative clinical trial].

A D Kulagin, B A Bakirov, I L Davydkin

|Sep 29, 2021
The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study.

Nikita V Lomakin, Bulat A Bakirov, Denis N Protsenko

|Jun 01, 2021
Efficacy and Safety of Netakimab, A Novel Anti-IL-17 Monoclonal Antibody, in Patients with Moderate to Severe Plaque Psoriasis. Results of A 54-Week Randomized Double-Blind Placebo-Controlled PLANETA Clinical Trial.

Luís Puig, Andrey L Bakulev, Muza M Kokhan

Pageof 1

Frequent Collaborators

4 joint publications

Arina V Zinkina-Orikhan

4 joint publications

Yulia N Linkova

3 joint publications

Vadim I Mazurov

2 joint publications

Bulat A Bakirov